Hematology

Despite therapeutic advances, delayed diagnosis of amyloid light-chain amyloidosis remains a major clinical challenge, according to data shared at the 2025 COMy Congress.

A large-scale study involving over 28,000 women has demonstrated the effectiveness of next-generation sequencing (NGS) in identifying thalassemia carriers and preventing severe cases of the genetic blood disorder…

Latest data from the global ALLELE study confirms the benefits of tabelecleucel cell therapy for transplant recipients who go on to develop a rare but often fatal blood cancer.

THE 51st Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) was held this year in the vibrant city of…

In the evolving landscape of haematologic cancers, the concept of minimal residual disease, also known as measurable residual disease…

A groundbreaking study has introduced a novel, image-based blood test that could significantly enhance the way doctors manage and personalise treatment for coronary artery disease (CAD), a leading global cause of death.

A novel form of CAR T-cell therapy, engineered to enhance immune response, is showing encouraging results in patients with relapsed or refractory lymphoma who previously failed anti-CD19 CAR T-cell treatment.